{"database":"ENA","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Fastqsanger.gz":["ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR206/040/SRR20652440/SRR20652440.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR206/037/SRR20652437/SRR20652437.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR206/033/SRR20652433/SRR20652433.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR206/041/SRR20652441/SRR20652441.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR206/038/SRR20652438/SRR20652438.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR206/039/SRR20652439/SRR20652439.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR206/036/SRR20652436/SRR20652436.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR206/035/SRR20652435/SRR20652435.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR206/034/SRR20652434/SRR20652434.fastq.gz"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["Guangdong Medical University"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA862390"],"scientific_name":["Homo sapiens"],"tag":["xref:PubMed:37456058"],"long_description":["To explore the characteristics of senescent melanoma cells induced by vemurafenib or cisplatin, melanoma A375 cells were treated with vemurafenib and cisplatin, respectively. The senescent phenotypes were verified by β-gal staining, EdU assay, cell morphology and the senescence-related pathways. RNA-seq was performed to explore the differentially expressed genes in the senescent cells induced by vemurafenib or cisplatin. Overall design: Melanoma A375 cells were treated with vemurafenib (10 μM) for 3 days or with cisplatin (2 μM) for 1 day and then returned to normal culture conditions. At day 7 after the treatment, A375 cells were collected and used for RNA-seq and other detections. Normal cultured A375 cells were simultaneously collected and acted as negative control."],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"Vemurafenib induces a noncanonical senescence-associated secretory phenotype in melanoma cells which promotes vemurafenib resistance","description":"Vemurafenib induces a noncanonical senescence-associated secretory phenotype in melanoma cells which promotes vemurafenib resistance","dates":{"last_updated":"2025-09-24","first_public":"2023-07-08"},"accession":"PRJNA862390","cross_references":{"GEO":["GSE209769"],"taxon":["9606"],"PubMed":["37456058"]}}